Kennedy last week announced he would “retire” the entire panel that guides U.S. vaccine policy. He also quietly removed Dr.

A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...

A Centers for Disease Control and Prevention official who led the agency's network to study hospitalization trends from ...

Fiona Havers, who oversaw CDC respiratory virus data, told colleagues she no longer had confidence the data would be used ...

The 17 members of the CDC's vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left ...

A Seattle infectious disease doctor, whose work was pivotal early in the COVID pandemic, shares more on her experience with ...

Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the ...

Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's ...

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...

The CDC currently recommends a single dose of the ... Morningstar's Anderson projects the total RSV vaccine market to be worth about $3.9 billion by 2030 globally, with Moderna gaining about ...